Compare BridgeBio Pharma Inc (BBIO) vs Valero Energy Corporation (VLO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Valero Energy Corporation — how do they compare? BridgeBio Pharma Inc trades at $83.9 (market cap $16.36B), while Valero Energy Corporation trades at $323.14 (market cap $93.27B). The key difference: Valero Energy Corporation is far larger — about 5.7× BridgeBio Pharma Inc's market cap, and Valero Energy Corporation pays a 1.48% dividend while BridgeBio Pharma Inc pays none. Which is the better fit depends on your goals.
| BBIO | VLO | |
|---|---|---|
Market Cap | $16.36B | $93.27B |
Sector | Health | Energy |
52-Week High | $90.17 | $323.92 |
52-Week Low | $47.29 | $133.38 |
Enterprise Value | $18.14B | $96.74B |
Dividend Yield | — | 1.48% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Valero Energy Corporation
Valero Energy is one of the largest independent refiners in the United States. It operates 14 refineries with a total throughput capacity of 3.2 million barrels a day in the United States, Canada, and the United Kingdom. Valero also owns 14 ethanol plants with capacity of 1.7 billion gallons of ethanol a year and holds a 50% stake in Diamond Green Diesel, which has capacity to produce 700 million gallons per year of renewable diesel.
Read more on VLO →
